These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32775395)

  • 1. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report.
    Wang XT; Guo W; Sun M; Han W; Du ZH; Wang XX; Du BB; Bai O
    World J Clin Cases; 2020 Jul; 8(14):3122-3129. PubMed ID: 32775395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
    Wang Q; Jiang Y; Zhu Q; Duan Y; Chen X; Xu T; Jin Z; Li C; Wu D; Huang H
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3441-3445. PubMed ID: 33856526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
    Shi Y; Dong M; Hong X; Zhang W; Feng J; Zhu J; Yu L; Ke X; Huang H; Shen Z; Fan Y; Li W; Zhao X; Qi J; Huang H; Zhou D; Ning Z; Lu X
    Ann Oncol; 2015 Aug; 26(8):1766-71. PubMed ID: 26105599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report.
    He ZD; Yang HY; Zhou SS; Wang M; Mo QL; Huang FX; Peng ZG
    World J Clin Cases; 2022 Feb; 10(4):1341-1348. PubMed ID: 35211568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic T-cell lymphoma presented with massive splenomegaly and pancytopenia - a case report.
    Sukrisman L; Rajabto W; Harahap AS; Fanggidae ESDE; Ham MF; Priantono D
    Klin Onkol; 2023; 36(3):246-250. PubMed ID: 37353354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chidamide induces long-term remission in rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.
    Li L; Wu C; Chai Y; Dong C; Zhao L
    Int J Immunopathol Pharmacol; 2021; 35():20587384211009342. PubMed ID: 33845613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chidamide based combination regimen for treatment of monomorphic epitheliotropic intestinal T cell lymphoma following radical operation: Two case reports.
    Liu TZ; Zheng YJ; Zhang ZW; Li SS; Chen JT; Peng AH; Huang RW
    World J Clin Cases; 2020 Apr; 8(7):1278-1286. PubMed ID: 32337203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
    Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
    Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma.
    Gui L; Cao J; Ji D; Zhang H; Fan Q; Zhu J; Song Y; Jiang S; Ning Z; Yu J; Shi Y
    Chin J Cancer Res; 2021 Oct; 33(5):616-626. PubMed ID: 34815635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chidamide in the treatment of peripheral T-cell lymphoma.
    Chan TS; Tse E; Kwong YL
    Onco Targets Ther; 2017; 10():347-352. PubMed ID: 28138258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
    Shi Y; Jia B; Xu W; Li W; Liu T; Liu P; Zhao W; Zhang H; Sun X; Yang H; Zhang X; Jin J; Jin Z; Li Z; Qiu L; Dong M; Huang X; Luo Y; Wang X; Wang X; Wu J; Xu J; Yi P; Zhou J; He H; Liu L; Shen J; Tang X; Wang J; Yang J; Zeng Q; Zhang Z; Cai Z; Chen X; Ding K; Hou M; Huang H; Li X; Liang R; Liu Q; Song Y; Su H; Gao Y; Liu L; Luo J; Su L; Sun Z; Tan H; Wang H; Wang J; Wang S; Zhang H; Zhang X; Zhou D; Bai O; Wu G; Zhang L; Zhang Y
    J Hematol Oncol; 2017 Mar; 10(1):69. PubMed ID: 28298231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China.
    Lu X; Ning Z; Li Z; Cao H; Wang X
    Intractable Rare Dis Res; 2016 Aug; 5(3):185-91. PubMed ID: 27672541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chidamide tablets: HDAC inhibition to treat lymphoma.
    Xu Y; Zhang P; Liu Y
    Drugs Today (Barc); 2017 Mar; 53(3):167-176. PubMed ID: 28447074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chidamide in combination with azacitidine for an elderly patient with peripheral T cell lymphoma‑not otherwise specified: A case report.
    Liu H; Xue F; Zhou R; Tian H; Mao J; Wu T
    Oncol Lett; 2024 Aug; 28(2):341. PubMed ID: 38855506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.
    Chen J; Zuo Z; Gao Y; Yao X; Guan P; Wang Y; Li Z; Liu Z; Hong JH; Deng P; Chan JY; Cheah DMZ; Lim J; Chai KXY; Chia BKH; Pang JWL; Koh J; Huang D; He H; Sun Y; Liu L; Liu S; Huang Y; Wang X; You H; Saraf SA; Grigoropoulos NF; Li X; Bei J; Kang T; Lim ST; Teh BT; Huang H; Ong CK; Tan J
    Clin Epigenetics; 2023 Feb; 15(1):19. PubMed ID: 36740715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation.
    Sun K; Sanchez CG; Pingali SR; Iyer S
    Ecancermedicalscience; 2018; 12():872. PubMed ID: 30483352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
    Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
    Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.